{"name":"Rilmazafone","slug":"rilmazafone","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Rilmazafona","Rilmazafonum","S 450191","S-450191","Rilmazafonum [Latin]","Rilmazafona [Spanish]","Ex-a5707","Da-57446","5-(((2-Aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide"],"brands":[],"scraped":true,"has_structure":true,"cid":5069,"classes":[],"families":[{"name":"aniline","href":"/substituted/aniline"}],"physical":[{"label":"Molecular mass","value":"475.30 g/mol","copyable":false},{"label":"Predicted LogP","value":"2.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>21</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide","copyable":true},{"label":"SMILES","value":"CN(C)C(=O)C1=NN(C(=N1)CNC(=O)CN)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl","copyable":true},{"label":"InChI","value":"InChI=1S/C21H20Cl2N6O3/c1-28(2)21(32)20-26-17(11-25-18(30)10-24)29(27-20)16-8-7-12(22)9-14(16)19(31)13-5-3-4-6-15(13)23/h3-9H,10-11,24H2,1-2H3,(H,25,30)","copyable":true},{"label":"InChIKey","value":"KYHFRCPLIGODFH-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"99593-25-6","copyable":true},{"label":"UNII","value":"CU3H37T766","copyable":true},{"label":"PubChem CID","value":"5069","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"10.5 h (M-4 metabolite)","copyable":false},{"label":"Metabolism","value":"Aminopeptidase (intestinal); hepatic","copyable":false},{"label":"Excretion","value":"Urine (44–68% within 24 h, primarily as M-4)","copyable":false},{"label":"Routes of administration","value":"Oral (tablets)","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Rilmazafone hydrochloride","name":"hydrochloride","slug":"rilmazafone_hydrochloride","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A4","mechanisms":["induction","metabolism","inhibition"],"partners":75,"contraindicated":0},{"target":"GABRA1","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"CES","mechanisms":["metabolism"],"partners":1,"contraindicated":0}],"mechanism":null,"side_effects":null,"effects":null,"usernotes":[{"user":"magnus","user_slug":"magnus","external":false,"note":{"substance":"Rilmazafone","composite":false,"routes":[{"name":"Oral","dosage":null,"onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}},{"user":"nervewing","user_slug":"nervewing","external":false,"note":{"substance":"Rilmazafone","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Other","status":"Rx-only (<small>JP</small>)","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Rilmazafone"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5069"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q7334297"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB20558"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2107197"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A135767"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=99593-25-6"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0257231"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D08481"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID10244150"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Rilmazafone"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/CU3H37T766"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5069, Rilmazafone. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5069>https://pubchem.ncbi.nlm.nih.gov/compound/5069</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Rilmazafone. UNII: CU3H37T766. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CU3H37T766>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CU3H37T766</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 11:18:56","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 11:18:52","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 11:18:52","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 11:18:53","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 11:18:52","note":"hmdb.ca refused automated access to HMDB0257231"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 11:18:54","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 11:18:52","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 11:18:52","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 11:18:52","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 11:18:52","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 11:18:52","note":null}],"description":"Rilmazafone is a  substance."}